Literature DB >> 8834042

Fibrodysplasia ossificans progressiva in two half-sisters: evidence for maternal mosaicism.

H B Janoff1, M Muenke, L O Johnson, A Rosenberg, E M Shore, E Okereke, M Zasloff, F S Kaplan.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of connective tissue characterized by congenital malformation of the great toes and by progressive heterotopic ossification of the soft tissues in specific anatomic and temporal patterns. We observed classic findings of FOP in 2 Native American half-sisters with the same unaffected mother and different unaffected fathers. This is the first report of FOP in sibs from different pregnancies with unaffected parents. The findings in this family indicate the possibility of maternal gonadal mosaicism in FOP and provide important new data for genetic counseling in this disease.

Entities:  

Mesh:

Year:  1996        PMID: 8834042     DOI: 10.1002/(SICI)1096-8628(19960202)61:4<320::AID-AJMG4>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva.

Authors:  Nathalie Bravenboer; Dimitra Micha; James T Triffit; Alex N Bullock; Roberto Ravazollo; Renata Bocciardi; Maja di Rocco; J Coen Netelenbos; Peter Ten Dijke; Gonzalo Sánchez-Duffhues; Fred S Kaplan; Eileen M Shore; Robert J Pignolo; Petra Seemann; Francesc Ventura; Genevieve Beaujat; Elizabeth M W Eekhoff; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2015-01-21       Impact factor: 4.246

Review 2.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

Review 3.  Osteochondral diseases and fibrodysplasia ossificans progressiva.

Authors:  Antonio Morales-Piga; Frederick S Kaplan
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  Early diagnosis of fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Meiqi Xu; David L Glaser; Felicity Collins; Michael Connor; Joseph Kitterman; David Sillence; Elaine Zackai; Vardit Ravitsky; Michael Zasloff; Arupa Ganguly; Eileen M Shore
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

Review 5.  Genomic Context and Mechanisms of the ACVR1 Mutation in Fibrodysplasia Ossificans Progressiva.

Authors:  Roberto Ravazzolo; Renata Bocciardi
Journal:  Biomedicines       Date:  2021-02-05

6.  From mysteries to medicines: drug development for fibrodysplasia ossificans progressive.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Expert Opin Orphan Drugs       Date:  2013-08       Impact factor: 0.694

Review 7.  Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis.

Authors:  Frederick S Kaplan; Salin A Chakkalakal; Eileen M Shore
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

8.  A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene.

Authors:  Serena Cappato; Rasa Traberg; Jolita Gintautiene; Federico Zara; Renata Bocciardi
Journal:  Mol Genet Genomic Med       Date:  2021-08-04       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.